StockNews.com upgraded shares of Inogen (NASDAQ:INGN – Free Report) from a hold rating to a buy rating in a report released on Monday. Separately, Needham & Company LLC restated a “hold” rating on ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

Portable Oxygen Concentrator Market. According to a revised research study by Future Market Insights, the global portable ...

After more than two decades of being primarily known for exclusively selling one product, portable oxygen containers, Goleta-based Inogen has spent the last couple of years branching out. That is ...

Inogen (INGN) Company Description: Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.

More on INGN’s Robust Product Portfolio Inogen’s expanding product portfolio is a significant driver of its growth. It offers a range of oxygen concentrator solutions for both portable and ...

On the eve of theArab Health Exhibition Yuwell Medical held its 2025 Global Core Partner Conference in Dubai and announced a strategic investment and partnership with Inogen a leading US company in re ...

As one of the world's largest manufacturers of oxygen concentrators, Yuwell Medical is widely recognized for its strong R&D capabilities and advanced manufacturing capabilities. Inogen, a leading U.S.